|
EP3064490A1
|
|
Improved process for the preparation of eslicarbazepine and eslicarbazepine acetate
|
|
EP3064589A1
|
|
Enzymatic process for the preparation of testosterone and esters thereof
|
|
EP3064497A1
|
|
Dimer impurities of apixaban and method to remove them
|
|
EP3075724A1
|
|
Solid form of agomelatine
|
|
EP3015453A1
|
|
Process for the preparation of Clomiphene
|
|
EP3015454A1
|
|
Stable solid form of trans-Clomiphene citrate
|
|
EP2980086A1
|
|
Efficient process for the preparation of esomeprazole (S)-binol complex
|
|
EP2944631A1
|
|
Improved process for the preparation of Efavirenz
|
|
EP2937346A1
|
|
Co-crystals of lapatinib
|
|
CN103992258A
|
|
Preparation method for
|
|
EP2769979A1
|
|
Process for the preparation of key intermediates for the synthesis of Statins
|
|
WO2014023576A1
|
|
Process for the preparation of 2-cyanophenylboronic acid and esters thereof
|
|
EP2754662A1
|
|
Efficient process for the preparation of Lapatinib and salts thereof by means of new intermediates
|
|
EP2757095A1
|
|
Very efficient process for preparing an intermediate of Etoricoxib
|
|
EP2586777A1
|
|
Process for the preparation of 2-alkoxy-5-(pyridin-2-yl)pyridine, an intermediate of perampanel
|
|
EP2546247A1
|
|
Imatinib mesylate preparation procedure
|
|
EP2489661A1
|
|
Impurity of lapatinib and salts thereof
|
|
EP2468745A1
|
|
Process for the preparation of lapatinib and the salts thereof
|
|
CN102731374A
|
|
Improved process for preparing 1-(6-methylpyridin-3-yl)-2-[4-(methylsulfonyl)phenyl]ethanone, an intermediate of etoricoxib
|
|
EP2602249A1
|
|
Synthesis of rosuvastatin by means of co-crystals
|
